{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T15:49:10Z","timestamp":1675871350072},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T00:00:00Z","timestamp":1213401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s00101-008-1394-y","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T06:55:16Z","timestamp":1213253716000},"page":"794-802","source":"Crossref","is-referenced-by-count":2,"title":["Isch\u00e4mische Komplikationen in der Neurochirurgie"],"prefix":"10.1007","volume":"57","author":[{"given":"M. J.","family":"Merkel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Brambrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,14]]},"reference":[{"key":"1394_CR1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1523\/JNEUROSCI.4157-04.2005","volume":"25","author":"Allen","year":"2005","unstructured":"Allen NJ, Karadottir R, Attwell D (2005) A preferential role for glycolysis in preventing the anoxic depolarization of rat hippocampal area CA1 pyramidal cells. J Neurosci 25: 848\u2013859","journal-title":"J Neurosci"},{"key":"1394_CR2","first-page":"CD005400","volume":"Rev","author":"Arango","year":"2006","unstructured":"Arango MF, Mejia-Mantilla JH (2006) Magnesium for acute traumatic brain injury. Cochrane Database Syst Rev (4): CD005400","journal-title":"Cochrane Database Syst"},{"key":"1394_CR3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0143-4160(03)00141-6","volume":"34","author":"Arundine","year":"2003","unstructured":"Arundine M, Tymianski M (2003) Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell calcium 34: 325\u2013337","journal-title":"Cell calcium"},{"key":"1394_CR4","first-page":"819","volume":"25","author":"Badjatia","year":"2004","unstructured":"Badjatia N, Topcuoglu MA, Pryor JC et al. (2004) Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. Am J Neuroradiol 25: 819\u2013826","journal-title":"Am J Neuroradiol"},{"key":"1394_CR5","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/01.STR.26.11.2177","volume":"26","author":"Bailey","year":"1995","unstructured":"Bailey SJ, Wood NI, Samson NA et al. (1995) Failure of isradipine to reduce infarct size in mouse, gerbil, and rat models of cerebral ischemia. Stroke 26: 2177\u20132183","journal-title":"Stroke"},{"key":"1394_CR6","first-page":"1067","volume":"25","author":"Biondi","year":"2004","unstructured":"Biondi A, Ricciardi GK, Puybasset L et al. (2004) Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal hemorrhage: preliminary results. Am J Neuroradiol 25: 1067\u20131076","journal-title":"Am J Neuroradiol"},{"key":"1394_CR7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1067\/mcp.2002.128127","volume":"72","author":"Blardi","year":"2002","unstructured":"Blardi P, Urso R, De Lalla A et al. (2002) Nimodipine: drug pharmacokinetics and adenosine levels in patients affected by cerebral ischemia. Clin Pharmacol Ther 72: 556\u2013561","journal-title":"Clin Pharmacol Ther"},{"key":"1394_CR8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jtcvs.2005.11.018","volume":"131","author":"Bhudia","year":"2006","unstructured":"Bhudia SK, Cosgrove DM, Naugle RI et al. (2006) Magnesium as a neuroprotectant in cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 131: 853\u2013861","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1394_CR9","first-page":"CD000277","volume":"Rev","author":"Dorhout","year":"2007","unstructured":"Dorhout Mees SM, Rinkel GJ, Feigin VL et al. (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (3): CD000277","journal-title":"Cochrane Database Syst"},{"key":"1394_CR10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000016055","volume":"10","author":"Fogelholm","year":"2000","unstructured":"Fogelholm R, Erila T, Palomaki H et al. (2000) Effect of nimodipine on final infarct volume after acute ischemic stroke. Cerebrovasc Dis 10: 189\u2013193","journal-title":"Cerebrovasc Dis"},{"key":"1394_CR11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/13543784.14.5.579","volume":"14","author":"Gribkoff","year":"2005","unstructured":"Gribkoff VK, Winquist RJ (2005) Voltage-gated cation channel modulators for the treatment of stroke. Expert Opin Investig Drugs 14: 579\u2013592","journal-title":"Expert Opin Investig Drugs"},{"key":"1394_CR12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3171\/jns.1993.78.4.0537","volume":"78","author":"Haley","year":"1993","unstructured":"Haley EC Jr, Kassell NF, Torner JC (1993) A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78: 537\u2013547","journal-title":"J Neurosurg"},{"key":"1394_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2005.10.004","volume":"24","author":"Harukuni","year":"2006","unstructured":"Harukuni I, Bhardwaj A (2006) Mechanisms of brain injury after global cerebral ischemia. Neurol Clin 24: 1\u201321","journal-title":"Neurol Clin"},{"key":"1394_CR14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.STR.32.2.461","volume":"32","author":"Horn","year":"2001","unstructured":"Horn J, Haan R de, Vermeulen M, Limburg M (2001) Very early nimodipine use in stroke (VENUS). Stroke 32: 461\u2013465","journal-title":"Stroke"},{"key":"1394_CR15","first-page":"CD001928","volume":"Rev","author":"Horn","year":"2000","unstructured":"Horn J, Limburg M. (2000) Calcium antagonists for ischemic stroke. Cochrane Database Syst Rev (2): CD001928","journal-title":"Cochrane Database Syst"},{"key":"1394_CR16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.STR.27.4.593","volume":"27","author":"Legault","year":"1996","unstructured":"Legault C, Furberg CD, Wagenknecht LE et al. (1996) Nimodipine neuroprotection in cardiac valve replacement. Report of an early terminated trial. Stroke 27: 593\u2013598","journal-title":"Stroke"},{"key":"1394_CR17","first-page":"CD000565","volume":"Rev","author":"Langham","year":"2003","unstructured":"Langham J, Goldfrad C, Teasdale G et al. (2003) Calcium channel blockers for acute traumatic brain injury. Cochrane Database Syst Rev (4): CD000565","journal-title":"Cochrane Database Syst"},{"key":"1394_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0143-4160(02)00054-4","volume":"33","author":"Limbrick","year":"2003","unstructured":"Limbrick DD Jr, Sombati S, DeLorenzo RJ (2003) Calcium influx constitutes the ionic basis for the maintenance of glutamate-induced extended neuronal depolarization associated with hippocampal neuronal death. Cell Calcium 33: 69\u201381","journal-title":"Cell Calcium"},{"key":"1394_CR19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2165\/00003088-200241130-00007","volume":"41","author":"Lu","year":"2002","unstructured":"Lu J, Pfister M, Ferrari P et al. (2002) Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women. Clin Pharmacokinet 41: 1105\u20131113","journal-title":"Clin Pharmacokinet"},{"key":"1394_CR20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10143-005-0013-5","volume":"29","author":"Macdonald","year":"2006","unstructured":"Macdonald RL (2006) Management of cerebral vasospasm. Neurosurg Rev 29: 179\u2013193","journal-title":"Neurosurg Rev"},{"key":"1394_CR21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0006-8993(89)91188-8","volume":"482","author":"McIntosh","year":"1989","unstructured":"McIntosh TK, Vink R, Yamakami I, Faden AI (1989) Magnesium protects against neurological deficit after brain injury. Brain Res 482: 252\u2013260","journal-title":"Brain Res"},{"key":"1394_CR22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3171\/jns.1996.85.1.0117","volume":"85","author":"Marinov","year":"1996","unstructured":"Marinov MB, Harbaugh KS, Hoopes PJ et al. (1996) Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 85: 117\u2013124","journal-title":"J Neurosurg"},{"key":"1394_CR23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0028-3908(01)00181-2","volume":"42","author":"Martin","year":"2002","unstructured":"Martin DJ, McClelland D, Herd MB et al. (2002) Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. Neuropharmacology 42: 353\u2013366","journal-title":"Neuropharmacology"},{"key":"1394_CR24","first-page":"123","volume":"19","author":"Meloni","year":"2006","unstructured":"Meloni BP, Zhu H, Knuckey NW (2006) Is magnesium neuroprotective following global and focal cerebral ischaemia? A review of published studies. Magnes Res 19: 123\u2013137","journal-title":"Magnes Res"},{"key":"1394_CR25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(04)15490-1","volume":"363","author":"Muir","year":"2004","unstructured":"Muir KW, Lees KR, Ford I, Davis S (2004) Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke Trial): randomized controlled trial. Lancet 363: 439\u2013445","journal-title":"Lancet"},{"key":"1394_CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/jcbfm.1993.22","volume":"13","author":"Nilsson","year":"1993","unstructured":"Nilsson P, Hillered L, Olsson Y et al. (1993) Regional changes in interstitial K+ and Ca2+ levels following cortical compression contusion trauma in rats. J Cereb Blood Flow Metab 13: 183\u2013192","journal-title":"J Cereb Blood Flow Metab"},{"key":"1394_CR27","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","volume":"298","author":"Pickard","year":"1989","unstructured":"Pickard JD, Murray GD, Illingworth R et al. (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298: 636\u2013642","journal-title":"BMJ"},{"key":"1394_CR28","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1161\/01.STR.32.8.1860","volume":"32","author":"Roos","year":"2001","unstructured":"Roos YBEM, Levi M, Carroll TA et al. (2001) Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 32: 1860\u20131862","journal-title":"Stroke"},{"key":"1394_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.ccx.0000216575.03815.ee","volume":"12","author":"Sakowitz","year":"2006","unstructured":"Sakowitz OW, Unterberg AW (2006) Detecting and treating microvascular ischemia after subarachnoid hemorrhage. Curr Opin Crit Care 12: 103\u2013111","journal-title":"Curr Opin Crit Care"},{"key":"1394_CR30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.STR.0000124458.98123.52","volume":"35","author":"Saver","year":"2004","unstructured":"Saver JL, Kidwell C, Eckstein M, Starkman S (2004) Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 35: 106\u2013108","journal-title":"Stroke"},{"key":"1394_CR31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3171\/jns.1992.76.4.0571","volume":"76","author":"Shibuya","year":"1992","unstructured":"Shibuya M, Suzuki Y, Sugita K et al. (1992) Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo controlled double-blind trial. J Neurosurg 76: 571\u2013577","journal-title":"J Neurosurg"},{"key":"1394_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2005.06.003","volume":"238","author":"Shibuya","year":"2005","unstructured":"Shibuya M, Hirai S, Seto M et al. (2005) Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. J Neurol Sci 238: 31\u201339","journal-title":"J Neurol Sci"},{"key":"1394_CR33","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1227\/01.NEU.0000215868.40441.D9","volume":"58","author":"Schmid-Els\u00e4sser","year":"2006","unstructured":"Schmid-Els\u00e4sser R, Kunz M, Zausinger S et al. (2006) Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery 58: 1054\u20131065","journal-title":"Neurosurgery"},{"key":"1394_CR34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1474-4422(06)70630-5","volume":"6","author":"Temkin","year":"2007","unstructured":"Temkin NR, Anderson GD, Winn HR et al. (2007) Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 6: 29\u201338","journal-title":"Lancet Neurol"},{"key":"1394_CR35","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1021\/jm049923l","volume":"47","author":"Teodori","year":"2004","unstructured":"Teodori E, Baldi E, Dei S et al. (2004) Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain. J Med Chem 47: 6070\u20136081","journal-title":"J Med Chem"},{"key":"1394_CR36","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1474-4422(06)70582-8","volume":"5","author":"Vergouwen","year":"2006","unstructured":"Vergouwen MD, Vermeulen M, Roos YB (2006) Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review. Lancet Neurol 5: 1029\u20131032","journal-title":"Lancet Neurol"},{"key":"1394_CR37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2176\/nmc.46.421","volume":"46","author":"Zhao","year":"2006","unstructured":"Zhao J, Zhou D, Guo J et al. (2006) Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage. Neurol Med Chir 46: 421\u2013428","journal-title":"Neurol Med Chir"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-008-1394-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-008-1394-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-008-1394-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:57:03Z","timestamp":1558565823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-008-1394-y"}},"subtitle":["Einsatz von Kalziumantagonisten"],"short-title":[],"issued":{"date-parts":[[2008,6,14]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["1394"],"URL":"https:\/\/doi.org\/10.1007\/s00101-008-1394-y","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,14]]}}}